Staphylococcus aureus |
Subcutaneous infection of MRL/lpr worsens arthritis [127]; accidental introduction of S. aureus into MRL/lpr colony results in worse arthritis [128] |
|
S. aureus-derived superantigen SEB |
Chronic exposure of HLA-DQ8 transgenic mice to SEB results in lupus development [126]; bi-weekly intravenous injection of SEB into MRL/lpr mice reduces disease [131]; single injection of SEB into young pre-diseased MRL/lpr mice prevents disease [132]; intraperitoneal injection of SEB into MRL/lpr mice that were neonatally tolerized to this superantigen results in dramatically worse lupus disease symptoms [133] |
|
Salmonella enterica |
Intravenous injection of attenuated Salmonella into 2-month pre-diseased NZBWF1 mice results in reduced proteinuria and reduced anti-DNA autoantibody [142]; four intraperitoneal infections of virulent Salmonella into young pre-diseased NZBWF1 mice results in increased autoantibody titers [143] |
|
Escherichia coli |
Four intraperitoneal infections of E. coli into young pre-diseased NZBWF1 mice results in increased autoantibody titers [143] |
|
Streptococcus pneumoniae |
No direct studies on S. pneumoniae in lupus-prone strains of mice |
|
Mycobacterium leprae |
MRL/lpr lupus-prone mice were shown to be more susceptible to M. leprae footpad infection than non-obese diabetic (NOD) mice [113], but the effects of the infection on lupus symptoms were not tested. Injection of Hsp65 protein derived from M. leprae accelerates autoimmunity and increases mortality in NZBWF1 lupus-prone mice [166] |